文献速递妇科

新型冠状病毒肺炎疫情对卵巢癌女性生活质量的影响

Impact of the coronavirus disease 2019 pandemic on the quality of life for women with ovarian cancer.
PubMed 文献 · Am J Obstet Gynecol · 2020-06-26

该研究通过在线调查评估2020年3月30日至4月13日期间卵巢癌女性在新型冠状病毒肺炎(COVID-19)疫情期间的治疗中断与生活质量,共555人完成调查。33%经历癌症护理延迟,88.6%报告显著癌症担忧,51.4%有边缘或异常焦虑,26.5%有边缘或异常抑郁。年龄小于65岁、自述免疫受损和癌症护理延迟与更差的担忧、焦虑、抑郁独立相关。

要点

  • 33%的卵巢癌患者经历癌症护理延迟,其中手术延迟10/38(26.3%),非手术治疗延迟18/217(8.3%)。
  • 88.6%报告显著癌症担忧,51.4%有边缘或异常焦虑,26.5%有边缘或异常抑郁。
  • 年龄小于65岁和自述免疫受损独立预测更高的癌症担忧、焦虑和抑郁。

核心结论

  • COVID-19危机正在影响卵巢癌患者的护理,手术、治疗、预约、实验室检查和影像学检查被取消或延迟。
  • 年龄较小、推测免疫受损和癌症护理延迟与显著更高水平的癌症担忧、焦虑和抑郁相关。
  • 医护人员必须与患者合作平衡COVID-19和癌症的竞争风险,认识到沟通是改善生活质量的關鍵临床工具。

研究设计与样本

  • 当前或既往诊断为卵巢癌的女性完成了一项在线调查,调查聚焦治疗中断和生活质量。
  • 生活质量采用癌症担忧量表(Cancer Worry Scale)和医院焦虑抑郁量表(Hospital Anxiety and Depression Scale)测量。
  • 调查通过幸存者网络和社交媒体分发,共603名女性访问调查网站,555名(92.0%)完成调查。
  • 采用单变量和多变量线性回归分析评估参与者特征对生活质量问卷得分的影响。

主要发现

  • 共有来自41个州的603名女性在2020年3月30日至2020年4月13日期间访问调查网站,555名(92.0%)完成调查,中位年龄58岁(范围20-85)。
  • 完成调查时,217名参与者(43.3%)正在积极治疗;175名参与者(33%)经历了癌症护理某些方面的延迟。
  • 38名计划手术的参与者中10名(26.3%)经历延迟,217名计划非手术治疗参与者中18名(8.3%)经历延迟;133名(24.0%)医生预约延迟,84名(15.1%)实验室检查延迟,53名(9.6%)癌症相关影像延迟。
  • 88.6%(489名)报告显著癌症担忧,51.4%(285名)有边缘或异常焦虑,26.5%(147名)有边缘或异常抑郁。
  • 单变量分析中,年龄小于65岁、计划癌症治疗或癌症手术、肿瘤护理延迟、自述免疫受损和使用远程医疗均与更高癌症担忧水平相关;更高焦虑评分与年龄小于65岁和自述免疫受损相关;更高抑郁评分与年龄小于65岁、计划癌症手术、肿瘤护理延迟、自述免疫受损和使用远程医疗相关。

临床怎么用

  • 原文未据此给出推荐。
  • 作者指出医护人员必须与患者合作平衡COVID-19和癌症的竞争风险,并认识到沟通是改善生活质量的關鍵临床工具。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The coronavirus disease 2019 pandemic has resulted in unprecedented challenges for the oncology community. For people living with cancer, treatments are interrupted, surgeries cancelled, and regular oncology evaluations rescheduled. People with cancer and their physicians must balance plausible fears of coronavirus disease 2019 and cancer treatment with the consequences of delaying cancer care. OBJECTIVE: We aim to evaluate the experience of women with ovarian cancer during the coronavirus disease 2019 pandemic. STUDY DESIGN: Women with a current or previous diagnosis of ovarian cancer completed an online survey focusing on treatment interruptions and quality of life. The quality of life was measured with the Cancer Worry Scale and Hospital Anxiety and Depression Scale. The survey was distributed through survivor networks and social media. Univariate and multivariable linear regression analysis were used to evaluate the effect of participant characteristics on quality of life survey scores. RESULTS: A total of 603 women, from 41 states, visited the survey website between March 30, 2020, and April 13, 2020, and 555 (92.0%) completed the survey. The median age was 58 years (range, 20-85). At the time of survey completion, 217 participants (43.3%) were in active treatment. A total of 175 participants (33%) experienced a delay in some component of their cancer care. Ten (26.3%) of the 38 participants scheduled for surgery experienced a delay, as did 18 (8.3%) of the 217 participants scheduled for nonsurgical cancer treatment. A total of 133 participants (24.0%) had a delayed physician appointment, 84 (15.1%) laboratory tests, and 53 (9.6%) cancer-related imaging. Among the cohort, 88.6% (489) reported significant cancer worry, 51.4% (285) borderline or abnormal anxiety, and 26.5% (147) borderline or abnormal depression. On univariate analysis, age less than 65 years, being scheduled for cancer treatment or cancer surgery, delay in oncology care, being self-described as immunocompromised, and use of telemedicine were all associated with higher levels of cancer worry. Higher anxiety scores were associated with age less than 65 years and being self-described as immunocompromised. Higher depression scores were associated with age less than 65 years, being scheduled for cancer surgery, delay in oncology care, being self-described as immunocompromised, and use of telemedicine. On multivariable linear regression analysis, age less than 65 and being self-described as immunocompromised were independently predictive of greater cancer worry, anxiety, and depression, and delay in cancer care was predictive of anxiety and depression. CONCLUSION: The coronavirus disease 2019 crisis is affecting care of patients with ovarian cancer; surgeries, treatments, scheduled physician appointments, laboratory tests, and imaging are cancelled or delayed. Younger age, presumed immunocompromise, and delay in cancer care were associated with significantly higher levels of cancer worry, anxiety, and depression. Providers must work with patients to balance competing risks of coronavirus disease 2019 and cancer, recognizing that communication is a critical clinical tool to improve quality of life in these times.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Frey MK, Ellis AE, Zeligs K, et al. Impact of the coronavirus disease 2019 pandemic on the quality of life for women with ovarian cancer. Am J Obstet Gynecol. 2020. PMID: 32598911. doi:10.1016/j.ajog.2020.06.049

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。